Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron's attenuated clinica...
Saved in:
Published in | medRxiv : the preprint server for health sciences |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
22.08.2022
|
Online Access | Get more information |
Cover
Loading…
Abstract | South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron's attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% - 69%) in the rural cohort and 58% (95% CI, 61% - 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, -21% - 37%), 34% (95% CI, 17% - 48%), and 51% (95% CI, 39% - 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% - 72%) and 85% (95% CI, 76% - 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% - 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus. |
---|---|
AbstractList | South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties, Omicron displaced other globally circulating variants within 3 months of its emergence. Due to limited testing, Omicron's attenuated clinical severity, and an increased risk of reinfection, the size of the Omicron BA.1 and BA.2 subvariants (BA.1/2) wave remains poorly understood in South Africa and in many other countries. Using South African data from urban and rural cohorts closely monitored since the beginning of the pandemic, we analyzed sequential serum samples collected before, during, and after the Omicron BA.1/2 wave to infer infection rates and monitor changes in the immune histories of participants over time. Omicron BA.1/2 infection attack rates reached 65% (95% CI, 60% - 69%) in the rural cohort and 58% (95% CI, 61% - 74%) in the urban cohort, with repeat infections and vaccine breakthroughs accounting for >60% of all infections at both sites. Combined with previously collected data on pre-Omicron variant infections within the same cohorts, we identified 14 distinct categories of SARS-CoV-2 antigen exposure histories in the aftermath of the Omicron BA.1/2 wave, indicating a particularly fragmented immunologic landscape. Few individuals (<6%) remained naïve to SARS-CoV-2 and no exposure history category represented over 25% of the population at either cohort site. Further, cohort participants were more than twice as likely to get infected during the Omicron BA.1/2 wave, compared to the Delta wave. Prior infection with the ancestral strain (with D614G mutation), Beta, and Delta variants provided 13% (95% CI, -21% - 37%), 34% (95% CI, 17% - 48%), and 51% (95% CI, 39% - 60%) protection against Omicron BA.1/2 infection, respectively. Hybrid immunity (prior infection and vaccination) and repeated prior infections (without vaccination) reduced the risks of Omicron BA.1/2 infection by 60% (95% CI, 42% - 72%) and 85% (95% CI, 76% - 92%) respectively. Reinfections and vaccine breakthroughs had 41% (95% CI, 26% - 53%) lower risk of onward transmission than primary infections. Our study sheds light on a rapidly shifting landscape of population immunity, along with the changing characteristics of SARS-CoV-2, and how these factors interact to shape the success of emerging variants. Our findings are especially relevant to populations similar to South Africa with low SARS-CoV-2 vaccine coverage and a dominant contribution of immunity from prior infection. Looking forward, the study provides context for anticipating the long-term circulation of SARS-CoV-2 in populations no longer naïve to the virus. |
Author | Kleynhans, Jackie Viboud, Cécile Tempia, Stefano Wolter, Nicole Cohen, Cheryl von Gottberg, Anne Mkhencele, Thulisa McMorrow, Meredith L du Toit, Jacques D Martinson, Neil A Sun, Kaiyuan Kahn, Kathleen Moyes, Jocelyn Lebina, Limakatso Bhiman, Jinal N Carrim, Maimuna |
Author_xml | – sequence: 1 givenname: Kaiyuan surname: Sun fullname: Sun, Kaiyuan organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 2 givenname: Stefano surname: Tempia fullname: Tempia, Stefano organization: Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America – sequence: 3 givenname: Jackie surname: Kleynhans fullname: Kleynhans, Jackie organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 4 givenname: Anne surname: von Gottberg fullname: von Gottberg, Anne organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 5 givenname: Meredith L surname: McMorrow fullname: McMorrow, Meredith L organization: COVID-19 Response, Centers for Disease Control and Prevention, Atlanta, Georgia, United States – sequence: 6 givenname: Nicole surname: Wolter fullname: Wolter, Nicole organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 7 givenname: Jinal N surname: Bhiman fullname: Bhiman, Jinal N organization: SAMRC Antibody Immunity Unit, University of the Witwatersrand, Johannesburg, South Africa – sequence: 8 givenname: Jocelyn surname: Moyes fullname: Moyes, Jocelyn organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 9 givenname: Maimuna surname: Carrim fullname: Carrim, Maimuna organization: School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 10 givenname: Neil A surname: Martinson fullname: Martinson, Neil A organization: Johns Hopkins University Center for TB Research, Baltimore, Maryland, United States of America – sequence: 11 givenname: Kathleen surname: Kahn fullname: Kahn, Kathleen organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 12 givenname: Limakatso surname: Lebina fullname: Lebina, Limakatso organization: Perinatal HIV Research Unit, University of the Witwatersrand, South Africa – sequence: 13 givenname: Jacques D surname: du Toit fullname: du Toit, Jacques D organization: MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa – sequence: 14 givenname: Thulisa surname: Mkhencele fullname: Mkhencele, Thulisa organization: Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa – sequence: 15 givenname: Cécile surname: Viboud fullname: Viboud, Cécile organization: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, United States of America – sequence: 16 givenname: Cheryl surname: Cohen fullname: Cohen, Cheryl organization: School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36032973$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j81KxDAUhbNQ_Bl9AkHyAq3JTTu5XZaijjAwMFW3Q5Im00CblLYj9O11UFfnfGfxwbklFyEGS8gDZynnjD8BA0gZprxIAUBiUYgrci3WTEAhxQ1p9mrwTbfQqfVu9uFIfd-fQuzi0RvaqdBMRg2W_hQ62S87-nmh0dG63NdJFT8ToD7QubV013szxkDtqM5THU9zS0s3eqPuyKVT3WTv_3JFPl6e36tNst29vlXlNhk4ZiKxRmGGoHJUKAzmEmGthWFMCqldzrRoEDOVS81QG32GLC8KgxocSgewIo-_3uGke9schtH3alwO_3fhG6yyUjM |
ContentType | Journal Article |
CorporateAuthor | PHIRST group |
CorporateAuthor_xml | – name: PHIRST group |
DBID | NPM |
DOI | 10.1101/2022.08.19.22278993 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
ExternalDocumentID | 36032973 |
Genre | Preprint |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: NCIRD CDC HHS grantid: U01 IP001048 |
GroupedDBID | NPM |
ID | FETCH-LOGICAL-p1843-eca8482a58a83c857826b3c00737bf50b3d884a57b08bcbd8844599c8b2f87f22 |
IngestDate | Sat Nov 02 12:27:58 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p1843-eca8482a58a83c857826b3c00737bf50b3d884a57b08bcbd8844599c8b2f87f22 |
OpenAccessLink | https://doi.org/10.1101/2022.08.19.22278993 |
PMID | 36032973 |
ParticipantIDs | pubmed_primary_36032973 |
PublicationCentury | 2000 |
PublicationDate | 2022-Aug-22 |
PublicationDateYYYYMMDD | 2022-08-22 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-Aug-22 day: 22 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | medRxiv : the preprint server for health sciences |
PublicationTitleAlternate | medRxiv |
PublicationYear | 2022 |
References | 36646700 - Nat Commun. 2023 Jan 16;14(1):246. doi: 10.1038/s41467-022-35652-0 |
References_xml | |
Score | 1.8543278 |
Snippet | South Africa was among the first countries to detect the SARS-CoV-2 Omicron variant. Propelled by increased transmissibility and immune escape properties,... |
SourceID | pubmed |
SourceType | Index Database |
Title | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36032973 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBXtCqMvY6Xdd4ce-mbUpf6UH0NZKYN-kKSjb0WSJWpYZJO5Zd2v372S7ISS0m0vxpESY3xOpCP53HsJOUiSIjNVqVmZq4ql6ihlQqWCKS3LPI5LIyUGJ5-d56dX6bfr7Hq5meOiSzp5qH6vjSv5H1ShDXDFKNl_QHa4KDTAOeALR0AYjn-F8US0dfXjIfp5WxtnX64x2sMPZ5EL4kV7k3s_ABOgXgT7xXQ8mbLj5juLe5fjxRx9eTbSC4FNrq5e5EsIrapXmDknv-r7qDeDtJgSs7ZdhFu7euEsiz6wMgoz66DYp3fWmzfqh7slIWd63nq37rTTRthmGP9hrLK3QeRjHoB6IOA95gFpuq43po1tcAaEvQtY9o4AwHj9yO0qBuCXMKXqUXnog3R9-cQVLNu5AzPJRwmW3Xq-91E67b5rk2wWHGt9nF-ehWxUcAtf1tzANnnZ_-jR2sNpkNlr8iosHujYM2GHbGi7S6rAAtqzgK6wgA4soHBCexbQxtAlC2htKcBJAwsosACbHAuoZ8EeuTr5Ojs-ZaF2Bmuxgg_TSvCUxyLjgieKY9GCXCYKX8wW0mQjmVScpyIr5IhLJfFDmpWl4jI2vDBx_Ia8sI3V7wjNQWQnHKR6xXUqYEUNig5EX86VzDNdVu_JW_9QblqfIOWmf1wfnuz5SLaXfPhEtgz8I_U-yLtOfnaQ_AHc-1Be |
link.rule.ids | 780 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rapidly+shifting+immunologic+landscape+and+severity+of+SARS-CoV-2+in+the+Omicron+era+in+South+Africa&rft.jtitle=medRxiv+%3A+the+preprint+server+for+health+sciences&rft.au=Sun%2C+Kaiyuan&rft.au=Tempia%2C+Stefano&rft.au=Kleynhans%2C+Jackie&rft.au=von+Gottberg%2C+Anne&rft.date=2022-08-22&rft_id=info:doi/10.1101%2F2022.08.19.22278993&rft_id=info%3Apmid%2F36032973&rft_id=info%3Apmid%2F36032973&rft.externalDocID=36032973 |